Healthcare Company Provides Assistance for Hemophiliac Children

2013/07/09

The Baxter Healthcare Trading (Shanghai) Co, Ltd donates goods and money worth more than 12.89 million yuan (US$ 2.1 million) at a donation ceremony in Beijing on July 5, 2013 to a program of the China Children and Teenagers' Fund (CCTF) to help disadvantaged children and families suffering from hemophilia. [Women of China/Fan Wenjun]

The Baxter Healthcare Trading (Shanghai) Co, Ltd donates goods and money worth more than 12.89 million yuan (US$ 2.1 million) at a donation ceremony in Beijing on July 5, 2013 to a program of the China Children and Teenagers' Fund (CCTF) to help disadvantaged children and families suffering from hemophilia. [Women of China/Fan Wenjun]

The Baxter Healthcare Trading (Shanghai) Co, Ltd donated goods and money worth more than 12.89 million yuan (US$ 2.1 million) at a donation ceremony in Beijing on July 5, 2013 to a program of the China Children and Teenagers' Fund (CCTF) to help disadvantaged children and families suffering from hemophilia.

Hemophilia is any of several hereditary blood-coagulation disorders in which the blood fails to clot normally because of a deficiency or abnormality of one of the clotting factors which stops bleeding when a blood vessel is broken. It is a recessive trait associated with the X-chromosome.

Baxter donated products of the most widely-used anti-hemophiliac factor VIII-Advate to needy children and families, to ease their financial burdens. The factor will prevent disablities caused by hemophilia. Concerned children and families in 15 cities in China including Beijing and Guangzhou will benefit from the program until 2014.

Sanjay Prabhakaran, Baxter's general manager for the Chinese mainland and Hong Kong, said his company had focused on prevention and treatment of hemophilia for more than 60 years and they would continue providing help for afflicted Chinese children.

Baxter, a pioneer of medical treatment for hemophilia, has donated more than 5 million units of VIII-Advate to Chinese hemophilia patients in recent years.

Secretary General of the CCTF Chen Xiaoxia said the fund would continue implementing charity projects for children, and it was hoped children with hemophilia would enjoy the same free and healthy lives as other children after receiving effective treatment.

Statistics show children account for 50 percent of the 10,353 patients with hemophilia in China. Preventative medical treatment enables children with hemophilia to exercise and grow up healthily although it hasn't been widely publicized in China because people do not have enough knowledge about the subject or can't afford to pay for treatment. 

Secretary General of the CCTF Chen Xiaoxia talks at the donation ceremony. [Women of China/Fan Wenjun]

Secretary General of the CCTF Chen Xiaoxia talks at the donation ceremony. [Women of China/Fan Wenjun]

 
Sanjay Prabhakaran, general manager for Chinese mainland and Hong Kong at Baxter, gives a speech at the donation ceremony. [Women of China/Fan Wenjun]

Sanjay Prabhakaran, general manager for Chinese mainland and Hong Kong at Baxter, gives a speech at the donation ceremony. [Women of China/Fan Wenjun]

 
Professor at the Beijing Children's Hospital Wu Runhui talks about the prevention of and medical treatment of hemophilia at the donation ceremony. [Women of China/Fan Wenjun]

Professor at the Beijing Children's Hospital Wu Runhui talks about the prevention of and medical treatment of hemophilia at the donation ceremony. [Women of China/Fan Wenjun]

 
A parent of a child with hemophilia talks about the present situation of medical treatment for hemophilia. [Women of China/Fan Wenjun]

A parent of a child with hemophilia talks about the present situation of medical treatment for hemophilia. [Women of China/Fan Wenjun]


 
(womeofchina.cn)